Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2023-01-03 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. It mentions the 'FCA' (Financial Conduct Authority) and uses RNS numbering, indicating a regulatory announcement. Specifically, it details the 'Resulting situation' of voting rights and the 'Date on which the threshold was crossed or reached' (23 December 2022). This directly corresponds to the definition of a Major Shareholding Notification.
2023-01-03 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and contains standard boilerplate language from RNS, the news service of the London Stock Exchange. The content details a 'Block Listing Six Monthly Return' covering the period from June 28, 2022, to December 28, 2022, specifically tracking the balance of unallotted securities under various share option plans. This type of filing, which reports on the issuance or allotment of shares under employee schemes, is a specific regulatory disclosure. While it relates to capital structure, it is not a general financing announcement (CAP) or a general share issue (SHA). Since it is a formal regulatory announcement distributed via RNS that doesn't fit perfectly into the other specific categories (like 10-K, ER, DIV, etc.), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly distributed through that system and serves a mandatory disclosure function.
2022-12-29 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 6196K' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings', which details changes in voting rights and share ownership thresholds crossed by specific entities (DBAY Advisors Limited, etc.). This type of filing specifically reports changes in significant share ownership, which corresponds directly to the definition for Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific and appropriate classification.
2022-12-22 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 5954J" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" regarding an acquisition or disposal of voting rights by FMR LLC, which is a mandatory disclosure for significant shareholders. This type of filing, reporting changes in major shareholdings, falls under the category of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific and appropriate classification over the general RNS fallback.
2022-12-13 English
Update on Q4 Trading
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a brief update on Q4 trading, providing revised revenue and profit expectations for the year ending 31 December 2022, and announcing when the full trading update will be released (January 17, 2023). Since this is a short announcement regarding trading performance and future reporting, it fits the definition of an Earnings Release (ER) which covers initial announcements of periodical financial results (key highlights only). Although it mentions a future full trading update, the current document provides the key financial highlights/revisions for the period, making ER the most appropriate classification over RPA or RNS, which are more general or announcement-focused. FY 2022
2022-11-23 English
Management Update
Board/Management Information Classification · 99% confidence The document is a short announcement released via RNS (RNS Number: 3312H) on November 23, 2022. The core content is a 'Management update' stating that the CEO, Peter Butterfield, is taking time away and the CFO, Andrew Franklin, has assumed his responsibilities. This directly relates to changes in senior management. Therefore, the most appropriate classification is Board/Management Information (MANG). Although it uses the RNS distribution system, the specific content overrides the general RNS fallback.
2022-11-23 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.